Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 4/20 | 0.57 |
| ▸ | RAB9A | P51151 | 4/20 | 0.57 |
| ▸ | TP53 | P04637 | 3/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | GMNN | O75496 | 1/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31683908 | 1.00 | NPC1 (0.57) | NPC1RAB9ATP53SMN1; SMN2MAPT | |
| SCHEMBL23719776 | 0.83 | CYP3A4 (0.71) | NPC1RAB9ATP53SMN1; SMN2MAPT | |
| SCHEMBL29304151 | 0.80 | CYP3A4 (0.62) | NPC1RAB9ATP53SMN1; SMN2MAPT | |
| SCHEMBL23720081 | 0.80 | NPC1 (0.59) | NPC1RAB9ATP53SMN1; SMN2MAPT | |
| SCHEMBL31683903 | 0.80 | NPC1 (0.59) | NPC1RAB9ATP53SMN1; SMN2MAPT | |
| SCHEMBL21186212 | 0.79 | CYP3A4 (0.68) | NPC1RAB9ATP53SMN1; SMN2MAPT | |
| SCHEMBL21186270 | 0.76 | RAB9A (0.68) | NPC1RAB9ATP53SMN1; SMN2MAPT | |
| SCHEMBL21186023 | 0.76 | RAB9A (0.68) | NPC1RAB9ATP53SMN1; SMN2MAPT | |
| SCHEMBL11109859 | 0.76 | RAB9A (0.68) | NPC1RAB9ATP53SMN1; SMN2MAPT | |
| SCHEMBL23719775 | 0.76 | RAB9A (0.63) | NPC1RAB9ATP53SMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4097111-B9 | PYRIDO[2,3-E]OXAZINE DERIVATIVES AS AGRICULTURAL CHEMICALS | GLOBACHEM NV (BE) | 2025-10-29 | — | — | EP | disclosed |
| EP-4097111-B1 | PYRIDO[2,3-E]OXAZINE DERIVATIVES AS AGRICULTURAL CHEMICALS | GLOBACHEM NV (BE) | 2025-07-23 | — | — | EP | disclosed |
| US-20230151023-A1 | PYRIDO[2,3-E]OXAZINE DERIVATIVES AS AGRICULTURAL CHEMICALS | GLOBACHEM NV (BE) | 2023-05-18 | — | — | US | disclosed |
| US-20230151023-A1 | PYRIDO[2,3-E]OXAZINE DERIVATIVES AS AGRICULTURAL CHEMICALS | GLOBACHEM NV (BE) | 2023-05-18 | — | — | US | disclosed |
| US-20230151023-A1 | PYRIDO[2,3-E]OXAZINE DERIVATIVES AS AGRICULTURAL CHEMICALS | GLOBACHEM NV (BE) | 2023-05-18 | — | — | US | disclosed |
| WO-2021151919-A1 | PYRIDO[2,3-E]OXAZINE DERIVATIVES AS AGRICULTURAL CHEMICALS | GLOBACHEM NV (BE) | 2021-08-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230151023-A1 | PYRIDO[2,3-E]OXAZINE DERIVATIVES AS AGRICULTURAL CHEMICALS | PNPO, HPD, PDXK | NPC1 3280/4885RAB9A 4522/4885TP53 1844/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.